Value of cardiac magnetic resonance on the risk stratification of cardiomyopathies
- PMID: 37900906
- PMCID: PMC10600791
- DOI: 10.4330/wjc.v15.i10.487
Value of cardiac magnetic resonance on the risk stratification of cardiomyopathies
Abstract
Cardiomyopathies represent a diverse group of heart muscle diseases with varying etiologies, presenting a diagnostic challenge due to their heterogeneous manifestations. Regular evaluation using cardiac imaging techniques is imperative as symptoms can evolve over time. These imaging approaches are pivotal for accurate diagnosis, treatment planning, and optimizing prognostic outcomes. Among these, cardiovascular magnetic resonance (CMR) stands out for its ability to provide precise anatomical and functional assessments. This manuscript explores the significant contributions of CMR in the diagnosis and management of patients with cardiomyopathies, with special attention to risk stratification. CMR's high spatial resolution and tissue characterization capabilities enable early detection and differentiation of various cardiomyopathy subtypes. Additionally, it offers valuable insights into myocardial fibrosis, tissue viability, and left ventricular function, crucial parameters for risk stratification and predicting adverse cardiac events. By integrating CMR into clinical practice, clinicians can tailor patient-specific treatment plans, implement timely interventions, and optimize long-term prognosis. The non-invasive nature of CMR reduces the need for invasive procedures, minimizing patient discomfort. This review highlights the vital role of CMR in monitoring disease progression, guiding treatment decisions, and identifying potential complications in patients with cardiomyopathies. The utilization of CMR has significantly advanced our understanding and management of these complex cardiac conditions, leading to improved patient outcomes and a more personalized approach to care.
Keywords: Cardiac magnetic resonance; Cardiomyopathies; Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Prognosis; Restrictive cardiomyopathy.
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Figures
Similar articles
-
CT and MR Imaging of Cardiomyopathies in Clinical Practice-An Approach After an Abnormal Echocardiogram or Electrocardiogram.Echocardiography. 2025 Feb;42(2):e70104. doi: 10.1111/echo.70104. Echocardiography. 2025. PMID: 39963998 Review.
-
The Role of MRI in Prognostic Stratification of Cardiomyopathies.Curr Cardiol Rep. 2020 Jun 19;22(8):61. doi: 10.1007/s11886-020-01311-3. Curr Cardiol Rep. 2020. PMID: 32562090 Review.
-
The Role of Magnetic Resonance Imaging in Cardiomyopathies in the Light of New Guidelines: A Focus on Tissue Mapping.J Clin Med. 2024 Apr 29;13(9):2621. doi: 10.3390/jcm13092621. J Clin Med. 2024. PMID: 38731153 Free PMC article. Review.
-
Advancing Cardiovascular Diagnostics: The Expanding Role of CMR in Heart Failure and Cardiomyopathies.J Clin Med. 2025 Jan 28;14(3):865. doi: 10.3390/jcm14030865. J Clin Med. 2025. PMID: 39941536 Free PMC article. Review.
-
Advanced Non-invasive Imaging Techniques in Chronic Heart Failure and Cardiomyopathies : Focus on Cardiac Magnetic Resonance Imaging and Computed Tomographic.Adv Exp Med Biol. 2018;1067:183-196. doi: 10.1007/5584_2018_183. Adv Exp Med Biol. 2018. PMID: 29498024 Review.
Cited by
-
RGD-modified ZIF-8 nanoparticles as a drug carrier for MR imaging and targeted drug delivery in myocardial infarction.Nanomedicine (Lond). 2024;19(18-20):1585-1600. doi: 10.1080/17435889.2024.2365623. Epub 2024 Jul 16. Nanomedicine (Lond). 2024. PMID: 39011901 Free PMC article.
-
Limitations and enhancement opportunities for variceal rebleeding prediction model in patients with cirrhosis.World J Gastroenterol. 2025 Feb 28;31(8):102841. doi: 10.3748/wjg.v31.i8.102841. World J Gastroenterol. 2025. PMID: 40062338 Free PMC article.
References
-
- Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270–276. - PubMed
-
- Yang Z, Huang L. Editorial for "The Impact of Hypertension on Left Ventricular Function and Remodeling in Non-Ischemic Dilated Cardiomyopathy Patients: A 3.0 T MRI Study". J Magn Reson Imaging. 2023;58:172–173. - PubMed
Publication types
LinkOut - more resources
Full Text Sources